BioSpace News Archive

G1 Therapeutics, Inc., a clinical-stage oncology company, announced that the company has entered into a debt financing agreement with Hercules Capital, Inc. for up to $100 million.

Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced that its management team will be presenting at the virtual Goldman Sachs 41st Annual Global Healthcare Conference on June 11, 2020.

Kleo Pharmaceuticals, Inc., a leading company in the field of developing next-generation, fully synthetic bispecific compounds designed to emulate or enhance the activity of biologics, announced that it will present at the Jefferies Virtual Healthcare Conference 2020 on Thursday, June 4, 2020 at 4:00 p.m. ET.

Intellia Therapeutics, Inc., a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, announced that it has commenced an underwritten public offering of $75 million of shares of its common stock.

Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced that Bill Lundberg, M.D., Chief Executive Officer, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020, at 3:30 p.m. ET.

Arena Pharmaceuticals, Inc. announced the completion of its previously announced underwritten public offering of 6,325,000 shares of its common stock at a price to the public of $50.00 per share, including 825,000 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares.

Gilead Sciences, Inc. announced that Mark Genovese, MD, has been appointed Senior Vice President, Inflammation, with responsibility for overseeing the clinical development of the company’s investigational portfolio of treatments for inflammatory conditions.

Kaleido Biosciences, Inc., a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health, announced that it intends to sell, subject to market and other conditions, $30 million of shares of its common stock in an underwritten public offering.

The F.M. Kirby Foundation of Morristown, New Jersey, has given United Network for Organ Sharing $75,000 to help promote organ donations and increase the number of organ transplants during the COVID-19 pandemic.

Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced that members of its management team will participate in presentations and meetings at the Jefferies Virtual Healthcare Conference with institutional investors taking place June 2-4, 2020.